Biolase Technology Inc (NASDAQ:BIOL)
A medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
High volume breakout on 2/7/13
Recs
New iPlus is selling well, marketleader in dental hard tissue laser. Online store, new products coming
Recs
While the stock appears to have experienced tremendous revenue growth it really hasn't. 2010 was a horrid year for Biolase as Schein and Biolase were trying to disolver their partnership. Basically niether party was actively selling. True comparisions should be made against FY2009. In the second quarter Biolase had revenues of ~$14 and that was the worst second quarter since 2003.
Recs
This business hasn't reached "critical mass" yet. Once you've had laser - you never want to go back to shots or drilling. It's kind of like the ultimate marketing product. It literally takes away the pain. Not only that, but because laser only affects the cavity, it leaves more tooth structure. So you keep your teeth longer. Proof? My 7 year old daughter had 5 cavities filled with the laser. No shots, no pain meds. I asked her how it was to have 5 cavities filled - my sensitive little red head said "It tickled a bit". Cool. OK, now the pressure is on traditional dentists. "Do you have laser?' It's a question that will continue to haunt them, until they buy one. BioLase is their entry tool. If these past few months are any indication, they may finally be getting their act together.
Recs
Low Public Opinion with Low Relative Strength
Recs
Recs
I own like 250 of this stock. i bought it at 2.90 or something like that. If you look at this company's history and their product and its potential, and the new managment who is a legend, then it's easy to see why I think this stock will be in mid 20's in a matter of a year. And I don't think this stock will ever come down until they are bought by a big corporation like GE or some other big company.
Recs
They have new technologies and a new CEO.
Recs
Has New Patents, Low P/E , More Good News then Bad
Recs
at $5.50, downside risk is minimal. timing couldnt be better. check out 4th quarter stock performace on the 5 year chart.
Recs
Future earnings potential and P&G deal.
Recs
WW leader in dental lasers with low penetration (significant pdtvty and ROI tool for dentists) significantly enhanced marketing wise by $5bln Harvey Shein. New pdts incorp more disposables. 40% int"l sales.
Undergoing impressive instl accumulation and bottomed.
Close to 25 days Short Interest to cover.
Recs
Biolase is going to have trouble expanding because it only currently sells one product. There is a limited supply that the company can sell to companies.
Recs
I liked this stock at 8 1/2 and it rose to over 10. So I gotta like it at 7 1/4. I still see it in double digits. I'm picking it at 7.18 i think it might go down to 7 which is where i would like to buy it. This is a company that leads its sector. its new product is lagging a little bit, but I beleive they signed the right distributor and soon they will be making those "Black Smiles"
Recs
Leader in laser denistry. Will rebound
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 15 of 15